Abstract:
본발명은 ADHD 검출용조성물, 키트, ADHD를확인하기위한정보제공및 ADHD 약물을스크리닝하는방법에관한것이다. 본발명에따른유전자마커를이용한 ADHD 검출용조성물은 ADHD를효과적으로검출할수 있을뿐만아니라이의대표적증상인과잉행동, 주의력또는집중력결핍및 충동행동과관련된유전자마커를이용하여행동학적특성을유전적으로효과적으로검출할수 있으므로 ADHD를조기에진단하고 ADHD를치료하기위한약물의스크리닝에이용할수 있다.
Abstract translation:本发明涉及用于检测ADHD的组合物,试剂盒和提供确认ADHD和用于筛选ADHD药物的信息的方法。 在本发明中使用遗传标记物检测ADHD的组合物可以有效地检测ADHD,并且可以遗传上有效地检测与ADHD的代表性症状相关的行为特征,例如多动症,注意力不集中或缺乏注意力以及冲动行为。 因此,该组合物可用于早期诊断ADHD并筛选用于治疗ADHD的药物。 用于检测ADHD的组合物包含:包含至少一种选自SEQ ID NO:1至SEQ ID NO:47所列基因组的基因的生物标志物; 以及对该基因特异的核酸或寡核苷酸,或对该基因编码的蛋白质特异的抗体。
Abstract:
The present invention provide a composition, a kit, and a microarray chip for confirming the addiction and dependence on drugs and a method for providing information for confirming the addiction and dependence on drugs. In particular, the present invention provides compositions, kits and microarray chips for confirming the addiction and dependence on drugs from at least one central nervous system stimulant selected among amphetamine, methamphetamine or methylphenidate and a method for providing information for confirming the addiction and dependence on drugs.
Abstract:
The present invention relates to a composition for preventing or treating diabetes containing a Chrysanthemi zawadskii extract as an active component. The composition is effective for treating and preventing diabetes by improving the expression amount of adiponectin, and promotes the differentiation of intermediate lobe stem cells into fat cells for improving the insulin sensitivity and controlling the blood sugar increase. [Reference numerals] (AA) IDX+ Chrysanthemi zawadskii extract 5ppm
Abstract:
The present invention relates to a composition for preventing or treating diabetes containing an Osterici radix extract as an active component. The composition is effective for treating and preventing diabetes by improving the expression amount of adiponectin, and promotes the differentiation of intermediate lobe stem cells into fat cells for improving the insulin sensitivity and controlling the blood sugar increase. [Reference numerals] (AA) IDX + Osterici radix extract 5ppm
Abstract:
본 발명은 강활 추출물을 유효성분으로 포함하는 당뇨병 치료 또는 예방용 조성물에 관한 것으로, 상기 조성물은 아디포넥틴 발현량을 증가시키고 중간엽줄기세포가 지방세포로 분화되는 것을 촉진하여 인슐린 감수성을 증가시킴으로써 혈당 상승을 억제하여 당뇨병 치료 및 예방에 효과적이다.